|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
1 Department of Microbiology, NYU School of Medicine, New York, NY 10016, USA
2 Department of Pathology, NYU School of Medicine, New York, NY 10016, USA
3 Department of Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, USA
*Author for correspondence (e-mail: basilc01{at}med.nyu.edu)
Accepted March 13, 2001
Unregulated FGF receptor signaling results in bone malformations that affect both endochondral and intramembranous ossification, and is the basis for several genetic forms of human dwarfism. FGF signaling inhibits chondrocyte proliferation and we have previously shown that the transcription factor STAT1 mediates the growth inhibitory effect of FGF in vitro. We provide genetic evidence that STAT1 is a modulator of the negative regulation of bone growth by FGF in vivo. We crossed Stat1-/- mice with a transgenic mouse line overexpressing human FGF2 (TgFGF). TgFGF mice exhibit phenotypes characterized by chondrodysplasia and macrocephaly, which affect endochondral and intramembranous ossification. We found that the chondrodysplasic phenotype of these mice results both from reduced proliferation and increased apoptosis of growth plate chondrocytes. Loss of STAT1 function in TgFGF mice led to a significant correction of the chondrodysplasic phenotype, but did not affect the skull malformations. The reduced proliferation of TgFGF growth plate chondrocytes, as well as their excessive apoptosis, were restored to near-normal levels in the absence of STAT1 function. Unregulated FGF signaling in TgFGF mice also induced apoptosis in calvarial osteoblasts that was not, however, corrected by the absence of STAT1. Detailed analysis of Stat1-/- growth plates uncovered a transient phenotype, characterized by an expansion of the proliferative zone and by acceleration of longitudinal bone growth, that attenuated as the animals grew older. These results document an essential role for STAT1 in FGF-mediated regulation of cell growth that is specific to the epiphyseal growth plate.
Key words: FGF, Bone development, STAT1, Apoptosis, Mouse, Chondrodysplasia
This article has been cited by other articles:
|
|
 |
|
  C. Ma, K. A. Bower, G. Chen, X. Shi, Z.-J. Ke, and J. Luo Interaction between ERK and GSK3{beta} Mediates Basic Fibroblast Growth Factor-induced Apoptosis in SK-N-MC Neuroblastoma Cells J. Biol. Chem., April 4, 2008; 283(14): 9248 - 9256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Krejci, L. Salazar, H. S. Goodridge, T. A. Kashiwada, M. J. Schibler, P. Jelinkova, L. M. Thompson, and W. R. Wilcox STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes J. Cell Sci., February 1, 2008; 121(3): 272 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Hutchison, M. H. Bassett, and P. C. White Insulin-Like Growth Factor-I and Fibroblast Growth Factor, But Not Growth Hormone, Affect Growth Plate Chondrocyte Proliferation Endocrinology, July 1, 2007; 148(7): 3122 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Yoon, R. Pogue, D. A. Ovchinnikov, I. Yoshii, Y. Mishina, R. R. Behringer, and K. M. Lyons BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways Development, December 1, 2006; 133(23): 4667 - 4678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schmerer, I. Torregroza, A. Pascal, M. Umbhauer, and T. Evans STAT5 acts as a repressor to regulate early embryonic erythropoiesis Blood, November 1, 2006; 108(9): 2989 - 2997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ben-Zvi, A. Yayon, A. Gertler, and E. Monsonego-Ornan Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling J. Cell Sci., January 15, 2006; 119(2): 380 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Barnard, A. J. Williams, B. Rabier, O. Chassande, J. Samarut, S.-y. Cheng, J. H. D. Bassett, and G. R. Williams Thyroid Hormones Regulate Fibroblast Growth Factor Receptor Signaling during Chondrogenesis Endocrinology, December 1, 2005; 146(12): 5568 - 5580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nowroozi, S. Raffioni, T. Wang, B. L. Apostol, R. A. Bradshaw, and L. M. Thompson Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells Hum. Mol. Genet., June 1, 2005; 14(11): 1529 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Halupa, M. L. Bailey, K. Huang, N. N. Iscove, D. E. Levy, and D. L. Barber A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution Blood, January 15, 2005; 105(2): 552 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-T. Chen, R. Levasseur, S. Vaishnav, G. Karsenty, and A. Bradley Bigenic Cre/loxP, pu{Delta}tk conditional genetic ablation Nucleic Acids Res., November 23, 2004; 32(20): e161 - e161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xiao, T. Naganawa, E. Obugunde, G. Gronowicz, D. M. Ornitz, J. D. Coffin, and M. M. Hurley Stat1 Controls Postnatal Bone Formation by Regulating Fibroblast Growth Factor Signaling in Osteoblasts J. Biol. Chem., June 25, 2004; 279(26): 27743 - 27752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Murakami, G. Balmes, S. McKinney, Z. Zhang, D. Givol, and B. de Crombrugghe Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype Genes & Dev., February 1, 2004; 18(3): 290 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Raucci, E. Laplantine, A. Mansukhani, and C. Basilico Activation of the ERK1/2 and p38 Mitogen-activated Protein Kinase Pathways Mediates Fibroblast Growth Factor-induced Growth Arrest of Chondrocytes J. Biol. Chem., January 16, 2004; 279(3): 1747 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, T. Koga, M. Isobe, B. E. Kern, T. Yokochi, Y. E. Chin, G. Karsenty, T. Taniguchi, and H. Takayanagi Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation Genes & Dev., August 15, 2003; 17(16): 1979 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Dailey, E. Laplantine, R. Priore, and C. Basilico A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation J. Cell Biol., June 23, 2003; 161(6): 1053 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Longobardi, M. Torello, C. Buckway, L. O'Rear, W. A. Horton, V. Hwa, C. T. Roberts Jr., F. Chiarelli, R. G. Rosenfeld, and A. Spagnoli A Novel Insulin-Like Growth Factor (IGF)-Independent Role for IGF Binding Protein-3 in Mesenchymal Chondroprogenitor Cell Apoptosis Endocrinology, May 1, 2003; 144(5): 1695 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Ballock and R. J. O'Keefe The Biology of the Growth Plate J. Bone Joint Surg. Am., March 31, 2003; 85(4): 715 - 726. [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Storm, J. L. R. Rubenstein, and G. R. Martin Dosage of Fgf8 determines whether cell survival is positively or negatively regulated in the developing forebrain PNAS, February 18, 2003; 100(4): 1757 - 1762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Laplantine, F. Rossi, M. Sahni, C. Basilico, and D. Cobrinik FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest J. Cell Biol., August 19, 2002; 158(4): 741 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Ornitz and P. J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes & Dev., June 15, 2002; 16(12): 1446 - 1465. [Full Text] [PDF]
|
|
|
|
|
|
A. Spagnoli, M. Torello, S. R. Nagalla, W. A. Horton, P. Pattee, V. Hwa, F. Chiarelli, C. T. Roberts Jr., and R. G. Rosenfeld Identification of STAT-1 as a Molecular Target of IGFBP-3 in the Process of Chondrogenesis J. Biol. Chem., May 17, 2002; 277(21): 18860 - 18867. [Abstract] [Full Text] [PDF]
|
|
